
1001 - 5000 employees
💊 Pharmaceuticals
🏥 Healthcare
🧬 Biotechnology
Pharmaceuticals • Healthcare • Biotechnology
Otsuka Pharmaceutical Companies (U. S. ) is a prominent player in the pharmaceutical manufacturing industry, dedicated to creating innovative products for better health worldwide. The company comprises two main entities: Otsuka America Pharmaceutical, Inc. (OAPI), which is focused on commercializing Otsuka-discovered and in-licensed products in North America, and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), which specializes in the clinical development and global registration of innovative healthcare solutions, particularly in the field of neuroscience.
🕒 November 3
🇺🇸 United States – Remote
💵 $169.2k - $253k / year
⏰ Full Time
🟠 Senior
🧪 Clinical Research
👻 Ghost score 0%
Where this job comes from
Posted on Otsuka Pharmaceutical Companies (U.S.)'s careers page ↗, not through a job board
First seen by Remote Rocketship November 3
Still open on Otsuka Pharmaceutical Companies (U.S.)'s site. Checked 3 hours ago.

1001 - 5000 employees
💊 Pharmaceuticals
🏥 Healthcare
🧬 Biotechnology
Pharmaceuticals • Healthcare • Biotechnology
Otsuka Pharmaceutical Companies (U. S. ) is a prominent player in the pharmaceutical manufacturing industry, dedicated to creating innovative products for better health worldwide. The company comprises two main entities: Otsuka America Pharmaceutical, Inc. (OAPI), which is focused on commercializing Otsuka-discovered and in-licensed products in North America, and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), which specializes in the clinical development and global registration of innovative healthcare solutions, particularly in the field of neuroscience.
• Develop and execute COA strategy for one or more assigned clinical programs • Identify fit-for-purpose PRO, ClinRO, ObsRO, and PerfO measures for assigned programs • Apply qualitative methods including concept elicitation, concept confirmation, and cognitive debriefing • Apply quantitative and psychometric methods to determine measurement properties, responder definitions, and meaningful change • Investigate COA availability, fitness for purpose, and regulatory precedent • Design and lead qualitative and quantitative COA evidence generation according to international scientific standards and health authority guidance • Contribute COA sections to regulatory dossiers, briefing packages, and health authority responses • Lead Patient Experience and COA evidence dossier development for external stakeholders • Coordinate COA licensing, translation, linguistic validation, and rater training • Serve as COA point of contact on assigned clinical study teams • Represent COA in cross-functional program governance • Represent Otsuka at relevant external conferences and working groups • Build and maintain relationships with academic institutions, patient advocacy groups, clinical investigators, data vendors, and relevant vendors • Own COA strategy for assigned programs and escalate cross-program or enterprise-level decisions to a Director
• Bachelor’s degree in outcomes research, health services research, epidemiology, psychology, public health, or a related field • 7+ years of relevant experience in COA/PRO or patient-centered outcomes research • At least 5 years specific to patient-centered/COA work • Demonstrated experience independently designing and executing COA evidence-generation projects • Working knowledge of FDA/EMA patient-focused drug development guidances and their application to clinical development • Comprehensive understanding of the pharmaceutical industry, global regulatory requirements, and product development processes across all life-cycle stages • Strong knowledge of the legal and regulatory environment influencing clinical development plans, labeling, and promotional claims • Experience partnering and collaborating with external vendors and academic/clinical investigators • Excellent written and verbal communication skills • Ability to present technical COA concepts to cross-functional and senior audiences • Preferred: Master or Doctoral degree in a relevant field • Preferred: Experience supporting an NDA/BLA/MAA regulatory submission with COA content • Preferred: Prior conference presentation or publication in COA/PRO methodology • Preferred: Experience across multiple therapeutic areas
• Comprehensive medical, dental, vision, and prescription drug coverage • Company-provided basic life insurance • Accidental death and dismemberment insurance • Short-term and long-term disability insurance • Tuition reimbursement • Student loan assistance • Generous 401(k) match • Flexible time off • Paid holidays • Paid leave programs • Other company-provided benefits • Incentive opportunity
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🕒 November 2
Senior Clinical Research Associate monitoring oncology clinical trials for ICON’s sponsor-dedicated research programs. Managing sites, inspections, data integrity, and regulatory compliance across South Florida.
🕒 November 2
Program Clinical Data Manager leading complex clinical data management programs for Worldwide Clinical Trials, a global contract research organization. Overseeing data quality, database lock, sponsors, and cross-functional teams.
🇺🇸 United States – Remote
💵 $99k - $196k / year
⏰ Full Time
🟠 Senior
🧪 Clinical Research
🦅 H1B Visa Sponsor
🕒 November 2
Senior Clinical Data Manager leading end-to-end data management for Worldwide Clinical Trials’ global clinical research projects. Overseeing data quality, database locks, budgets, risks, and cross-functional delivery.
🇺🇸 United States – Remote
💵 $79k - $157k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
🧪 Clinical Research
🦅 H1B Visa Sponsor
🕒 October 30
Clinical Study Manager overseeing sponsor-dedicated global clinical trials for ICON, a clinical research organization. Coordinating vendors, operational delivery, compliance, inspections, and study documentation.
🕒 October 30
Associate Director overseeing pharmacovigilance operations, vendors, compliance, and safety reporting. Supporting Liquidia’s pulmonary hypertension therapies across clinical trials and marketed products.